Crossmark

Exploring the therapeutic efficacy of Bai-Shao in mitigating comorbid epileptic seizures and cognitive impairment via inflammatory signaling pathways: insights from in silico and in vivo studies

Crossref DOI link: https://doi.org/10.1007/s13205-025-04316-3

Published Online: 2025-05-15

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Yanhong

Lv, Hailing

Liu, Xiaoyu

Liu, Aiju https://orcid.org/0009-0003-6251-9481
Funding

Funding for this research was provided by:

Shandong University (No number)
License Information

Text and Data Mining valid from 2025-05-15

Version of Record valid from 2025-05-15
More Information

Article History

Received: 20 February 2025

Accepted: 9 April 2025

First Online: 15 May 2025

Declarations

:

: The authors declare no potential conflicts of interest.

: The study was approved by Research Ethics Committee on the Care and Use of Laboratory Animals at Shandong Provincial Third Hospital, Shandong University(No: SDZY220028).

: N/A.

Document is current

Any future updates will be listed below